Skip to content

Prospective, randomized, open and blank controlled clinical study of Jindan Fuyan granule in the treatment of lymphatic cyst (damp heat accumulation syndrome) after lymphadenectomy for endometrial or cervical cancer

Prospective, randomized, open and blank controlled clinical study of Jindan Fuyan granule in the treatment of lymphatic cyst (damp heat accumulation syndrome) after lymphadenectomy for endometrial or cervical cancer

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050155
Enrollment
Unknown
Registered
2021-08-19
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphatic cyst

Interventions

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the criteria of Western medicine diagnosis of lymphatic cyst after lymphadenectomy for endometrial cancer or cervical cancer and TCM syndrome differentiation of damp heat accumulation syndrome; 2. It was confirmed by B-ultrasound imaging that it was a lymphatic cyst, and the maximum diameter and length of the cyst was >= 4cm; 3. Women aged from 18 to 65 years; 4. Those who voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant, pregnant or lactating women in the last three months; 2. It is complicated with serious primary diseases such as liver, kidney and hematopoietic system, and mental patients; 3. Related symptoms caused by other diseases confirmed by examination; 4. Patients who had been treated with the disease within two weeks; 5. Patients participating in other clinical trials; 6. Suspected or true history of alcohol and drug abuse, or other diseases or conditions that reduce the possibility of enrollment or complicate enrollment according to the judgment of the researcher, such as frequent changes in working environment, unstable living environment and other conditions that are easy to cause loss of follow-up; 7. The researcher believes that it is not suitable to be selected for this experiment due to other reasons; 8. The investigator assessed that alanine aminotransferase and / or aspartate aminotransferase >= 1.5 times the upper limit of normal value, and / or blood creatinine exceeds the upper limit of normal value, which is not suitable for the test; 9. Patients who need adjuvant radiotherapy and chemotherapy after surgery for endometrial or cervical cancer.

Design outcomes

Primary

MeasureTime frame
Change of lymphatic cyst size;

Countries

China

Contacts

Public ContactLi Qiling

The First Affiliated Hospital of Xi'an Jiaotong University

liqiling@mail.xjtu.edu.cn+86 18991232838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026